TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/10/21 16:02 | 12/8/21 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heath-Chiozzi Margo | NJ | O | SVP of R | M.d | 2 | 2.78 | 0 | 1 | 6 | 11 | D | ||||||||||||||
12/10/21 16:02 | 12/8/21 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heath-Chiozzi Margo | NJ | O | SVP of R | S.d | -24 | 40.00 | 0 | -1 | -5 | 11 | D | ||||||||||||||
11/3/21 16:02 | 11/1/21 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heath-Chiozzi Margo | NJ | O | SVP of R | M.d | 2 | 2.78 | 0 | 1 | 6 | 11 | D | ||||||||||||||
11/3/21 16:02 | 11/1/21 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heath-Chiozzi Margo | NJ | O | SVP of R | S.d | -25 | 41.71 | 0 | -1 | -5 | 11 | D | ||||||||||||||
8/13/21 06:59 | 8/11/21 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heath-Chiozzi Margo | NJ | O | SVP of R | M.d | 90 | 9.02 | 0 | 10 | 802 | 11 | D | ||||||||||||||
6/10/20 07:55 | 6/9/20 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heath-Chiozzi Margo | NJ | O | SVP of R | P | 3 | 3.01 | 0 | 1 | New | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |